Oncodrugs

        

 Home l Advertisements  l  Meetings l Contact  
 Editorial Board l Current Issue l Archives l For Authors l For Editors l For Reviewers l Submission l Fair Publication Peer Review l Author's Brief
WELCOME

Oncodrugs
 

OncoDrugs  (ISSN 2332-8967 (Online)) is a new online only peer reviewed journal that accepts  articles  from all disciplines related to oncology drugs and tumor biology.

OncoDrugs  applies the Creative Commons Attribution License (CCAL) to all manuscripts to be published.

Oncodrugs

 

Introducing

fair publication

peer-review

 

at no cost

0.00 U$D

publication fee

OncoDrugs accepts different type of Articles

  • Case reports  (Peer reviewed)

  • Editorials  (Non Peer reviewed)

  • Educational Technologies  (Peer reviewed)

  • Hypotheses  (Peer reviewed)

  • Invited Reviews (and unsolicited)  (Peer reviewed)

  • Mini-reviews (Peer reviewed)

  • New Drug Updates  (Peer reviewed)

  • Original Research Articles (Peer reviewed)

  • Short Communications (Peer reviewed)

  • Technical Notes (e.g., Methods & protocols) (Peer reviewed)

  • White Papers  (Non-Peer reviewed) & Author's Brief (Non- Peer reviewed)

  • Perspectives (Peer reviewed)

OncoDrugs offers fast peer-review and publication. Corresponding authors will receive a notification within 72 hrs that his/her manuscript is accepted or not for revision. All original articles submitted to OncoDrugs should be prepared according our journal style and will be reviewed within one month.

 

You own the copyrights: Authors who publish with OncoDrugs agree to the following terms: i). Authors retain copyright and grant OncoDrugs the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. ii). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. iii) Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Editorial Procedures

All manuscripts submitted to OncoDrugs are critically assessed by external and/or inhouse experts (One of our Editorial Board Member that has knowledge of the field discussed in the manuscript) in accordance with the principles of Peer Review  http://www.icmje.org . This first step takes place entirely inhouse.

 

All manuscripts are sent for review. The reviewers will provide and extensive revision and a list of all critics authors need to address. If a manuscript does not receive a sufficiently high priority score to warrant publication, authors will be asked to provide a detailed response to all reviewers comments and resubmit their work within 3 month.

In the second step, the articles are reviewed by at least one editor and one external referees.

 

The third step is the decision step by the Editor-In-Chief or and associate editor.

 

Oncodrugs

www.oncodrugs.org/journal               2013-2014.  All rights reserved.

 

 Pagerank